参考文献/References:
[1]NOSS E H, BRENNER M B. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis[J].Immunol Rev,2008,223:252-270.
[2]MULLER-LADNER U, GAY R E, GAY S. Activation of synoviocytes[J]. Curr Opin Rheumatol, 2000,12(3):186-194.
[3]YAMANISHI Y, BOYLE D L, GREEN D R, et al. p53 tumor suppressor gene mutations in fibroblast-like synoviocytes from erosion synovium and nonerosion synovium in rheumatoid arthritis[J]. Arthritis Res Ther ,2005,7(1):12-18.
[4]BAIER A, MEINECKEL I, GAY S, et al. Apoptosis in rheumatoid arthritis[J]. Curr Opin Rheumatol, 2003,15(3):274-279.
[5]储永良,黄清春,黄闫月,等.血栓素A2受体通过介导环氧酶2的合成增强类风湿关节炎滑膜细胞的增殖作用[J].中国病理生理杂志,2014(6):1110-1113.
[6]AUDO R, CALMON-HAMATY F, PAPON L, et al. Distinct effects of soluble and membrane bound Fas ligand on fibroblast-like synoviocytes from rheumatoid arthritis patients[J]. Arthr Rheumatol ,2014,66(12):3289-3299.
[7]GEORGANAS C, LIU H, PERLMAN H, et al. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun[J]. J Immunol ,2000,165(12):7199-7206.
[8]MIAGKOV A V, KOVALENKO D V, BROWN C E, et al. NF-kappa B activation provides the potential link between inflammation and hyperplasia in the arthritic joint[J]. Proc Natl Acad Sci USA ,1998,95(23):13859-13864.
[9]GRABIEC A M, ANGIOLILLI C, HARTKAMP L M, et al. JNK-dependent downregulation of FoxO1 is required to promote the survival of fibroblast-like synoviocytes in rheumatoid arthritis[J]. Ann Rheum Dis, 2015,74(9):1763-1771.
[10]KATO M, OSPELT C, GAY R E, et al. Dual role of autophagy in stress-induced cell death in rheumatoid arthritis synovial fibroblasts[J]. Arthr Rheumatol,2014,66(1):40-48.
[11]蔡永松,许鹏.类风湿关节炎滑膜成纤维细胞凋亡与自噬研究进展[J].中华风湿病学杂志,2014,18(5):341-344.
[12]PERLMAN H, PAGLIARI L J, LIU H, et al. Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis[J]. Arthritis Rheum,2001,44(1):21-30.
[13]MEINECKE I, CINSKI A, BAIER A, et al. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts[J]. Proc Natl Acad Sci USA, 2007,104(12):5073-5078.
[14]PERLMAN H, BRADLEY K, LIU H, et al. IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts[J]. J Immunol,2003,170(2):838-845.
[15]赵瑜,王林,潘继.miRNA在类风湿性关节炎中的研究进展[J].生命科学,2015,27(9): 1140-1145.
[16]于静雅,陈勇.PI3K-AKT信号通路及其在类风湿性关节炎滑膜细胞增殖和凋亡中的作用[J].细胞与分子免疫学杂志,2014(12):1326-1329.
[17]CONNOR A M, MAHOMED N, GANDHI R, et al. TNF alpha modulates protein degradation pathways in rheumatoid arthritis synovial fibroblasts[J]. Arthr Res Ther,2012,14(4):62.
[18]秦苏萍,孙德旭,李慧,等.IHH-Gli信号通路在CIA大鼠滑膜成纤维细胞增殖中的作用[J].免疫学杂志,2015(11):937-940.
[19]龚如涵,宗明,张慧,等.小干扰RNA沉默肽酰基精氨酸脱亚胺酶4基因对类风湿关节炎滑膜成纤维细胞凋亡的影响[J].中华风湿病学杂志,2014,18(7): 470-474.
[20]任洁,周毅,吴会霞,等.NKp44+NK细胞在类风湿关节炎滑膜增生及炎症中的作用[J].中华医学杂志, 2014, 94(3):201-203.
[21]LEE S Y, YOON B Y, KIM J I, et al. Interleukin-17 increases the expression of Tolllike receptor 3 via the STAT3 pathway in rheumatoid arthritis fibroblast-like synoviocytes[J]. Immunology, 2014,141(3):353-361.
[22]陈雪芳,王佳良.IL-37在类风湿性关节炎患者体内表达的研究[J].中国卫生检验杂志,2014(9):1280-1282.
[23]申健,王瑞琳,徐瑾,等.类风湿性关节炎滑膜组织中IFN-γ和IL-4的表达及意义[J].临床与实验病理学杂志,2014(5):519-522.
[24]周大兵,王瑞琳,徐瑾,等.类风湿性关节炎滑膜组织中IL-17和IL-10的表达及意义[J].临床与实验病理学杂志,2014(5):527-530.
[25]彭桉平,卢欣沂,何敏,等.IL-22 诱导类风湿关节炎患者滑膜成纤维细胞分泌IL-6 促进Th17细胞分化的研究[J].中华微生物学和免疫学杂志,2014,34(7):541-543.
[26]李会丹,孙悦,火蓉芬,等.组蛋白去乙酰化酶1通过NF—κB调控炎症性滑膜细胞表达Cyr61[J].现代免疫学,2014(1):1-6.
[27]翟天航,孙悦,火蓉芬,等.IL-17调控类风湿性关节炎滑膜细胞SENP6表达与Cyr61关系初探[J].现代免疫学, 2015(1):1-5.
[28]DONLIN L T, JAYATILLEKE A, GIANNOPOULOU E G, et al. Modulation of TNF-induced macrophage polarization by synovial fibroblasts[J]. J Immunol,2014,193(5):2373-2383.
[29]樊莎莎,宗明,陆英,等.体外实验经典活化型巨噬细胞抑制类风湿关节炎滑膜成纤维细胞增殖[J].中华风湿病学杂志,2015,19(8):540-544.
[30]刘振杰,张丹丹,李涛,等. RNAi下调MMP-14表达对类风湿关节炎滑膜细胞炎症因子分泌的影响[J].广东医学,2015(15): 2342-2345.
[31]TRENKMANN M, BROCK M, GAY R E, et al. Tumor necrosis factor α-induced microRNA-18a activates rheumatoid arthritis synovial fibroblasts through a feedback Loop in NF-κB signaling[J]. Arthritis Rheum, 2013, 65(4): 916-927.
[32]DONG L, WANG X, TAN J, et al. Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis[J].J Cell Mol Med, 2014,18(11):2213-2224.
[33]张晓军,刘健,万磊,等. 佐剂关节炎大鼠滑膜组织HIF-1α和VEGF及CD34表达上调促进血管新生[J]. 细胞与分子免疫学杂志,2015,31(8):1053-1056.
[34]MULLER-LADNER U, KRIEGSMANN J, FRANKLIN B N, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice[J]. Am J Pathol,1996,149(5):1607-1615.
[35]张璐,孔玮,任义乐,等.脐带间充质干细胞对类风湿关节炎滑膜成纤维细胞基质金属蛋白酶的影响[J].中华风湿病学杂志,2014(10):665-669.
[36]史栋梁,史桂荣.MicroRNA-16对类风湿关节炎患者滑膜成纤维细胞增殖、侵袭及细胞因子分泌的影响[J].中国病理生理杂志,2014(10):1868-1872.
[37]SHIGEYAMA Y, PAP T, KUNZLER P, et al. Expression of osteoclast differentiation factor in rheumatoid arthritis[J]. Arthritis Rheum ,2000,43(11):2523-2530.
[38]YOU S, YOO S A, CHOI S, et al. Identification of key regulators for the migration and invasion of rheumatoid synoviocytes through a systems approach[J]. Proc Natl Acad Sci U S A, 2014,111(1):550-555.
[39]STANFORD S M, MAESTRE M F, CAMPBELL A M, et al. Protein tyrosine phosphatase expression profile of rheumatoid arthritis fibroblast-like synoviocytes: a novel role of SH2 domain-containing phosphatase 2 as a modulator of invasion and survival[J]. Arthr Rheum, 2013,65(5):1171-1180.
[40]HOT A, ZRIOUAL S, LENIEF V, et al. IL-17 and tumour necrosis factor alpha combination induces a HIF-1alpha-dependent invasive phenotype in synoviocytes[J]. Ann Rheum Dis,2012,71(8):1393 -1401.
[41]PAP T, CLAUS A, OHTSU S, et al. Osteoclast-independent bone resorption by fibroblast-like cells[J]. Arthritis Res Ther, 2003, 5(3):163 -173.
[42]MULLER-LADNER U, OSPELT C, GAY S, et al. Cells of the synovium in rheumatoid arthritis.Synovia fibroblasts[J]. Arthritis Res Ther,2007,9(6):223.
[43]BARTOK B, FIRESTEIN G S. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis[J]. Immunol Rev,2010,233(1):233-255.
[44]ASSEFNIA S, DAKSHANAMURTHY S, GUIDRY AUVIL J M, et al. Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target,common therapies[J].Oncotarget, 2014,5(6):1458-1474.
[45]LEFVRE S, KNEDLA A, TENNIE C, et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints[J].Nat Med,2009,15(12):1414-1420.
[46]贺琤雯.HMGB1与LPS协同激活类风湿性关节炎滑膜成纤维细胞产生基质金属蛋白酶的分子机制[D].上海:第二军医大学,2011.
[47]MALEMUD C J. Growth hormone, VEGF and FGF: involvement in rheumatoid arthritis[J]. Clin Chim Acta ,2007,375(1-2):10-19.
[48]RICO M C, ROUGH J J, DEL CARPIO-CANO F E, et al. The axis of thrombospondin-1, transforming growth factor beta and connective tissue growth factor: an emerging therapeutic target in rheumatoid arthritis[J]. Curr Vasc Pharmacol,2010,8(3):338-343.
[49]ROSENGREN S, CORR M, BOYLE D L. Platelet-derived growth factor and transforming growth factor beta synergistically potentiate inflammatory mediator synthesis by fibroblast-like synoviocytes[J]. Arthritis Res Ther,2010,12(2): 65.
[50]TERABE F, KITANO M, KAWAI M, et al. Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway[J]. Mod Rheumatol,2009,19(5):522-529.
[51]郭欣,潘云峰,方霖楷,等.RICTOR在肿瘤坏死因子-α参与的类风湿关节炎成纤维样滑膜细胞活化中的作用[J].中华风湿病学杂志,2015,19(1):42-45.
[52]孙铁铮,吕厚山,药立波,等.TNF-α诱导类风湿关节炎滑膜成纤维细胞MAPKs通路的活化[J].中国免疫学杂志,2000(6):329-332.
[53]ARDOIN S P, PISETSKY D S. The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation[J]. Mod Rheumatol,2008,18(4):319-326.
[54]DISTLER J H, HUBER L C, GAY S, et al. Microparticles as mediators of cellular crosstalk in inflammatory disease[J]. Autoimmunity, 2006,39(8): 683-690.
[55]BOILARD E, NIGROVIC P A, LARABEE K, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production[J]. Science,2010,327(5965):580-583.
[56]MESSER L, ALSALEH G, FREYSSINET J M, et al. Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytes[J]. Arthritis Res Ther,2009,11(4):40.
[57]MOR A, ABRAMSON S B, PILLINGER M H. The fibroblast-like synovial cell in rheumatoid arthritis:a key player in inflammation and joint destruction[J].Clin Immunol,2005,115(2):118-128.
[58]FIRESTEIN G S, ECHEVERRI F, YEO M, et al. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium[J]. Proe Nan Acad Sci,1997,94(20):10895-10900.
[59]SUN Y, WENGER L. p53 down-regulates human matrix metalloproteinase-1(collagenase-1)gene expression[J]. J Biol Chem ,1999,274(17):11535-11540.
[60]SUN Y, CHEUNG J M, MARTEL-PELLETIER J, et al. Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3(hMMP-1 3) [J]. J Biol Chem,2000,275(15):11327-11332.
[61]JNGEL A, OSPELT C, GAY S.What can we learn from epigenetics in the year 2009[J]. Curr Opin Rheumatol,2010,22(3): 284-292.
[62]WADA T T, ARAKI Y, SATO K, et al. Aberrant histone acetylation contributes to elevated interleukin-6 production in rheumatoid arthritis synovial fibroblasts[J].Biochem Biophys Res Commun,2014,444(4):682-686.
[63]KAROUZAKIS E, GAY R E, MICHEL B A, et al. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts[J]. Arthritis Rheum,2009,60(12):3613-3622.
[64]KAROUZAKIS E, RENGEL Y, JUNGEL A, et al. DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts[J]. Genes Immun,2011,12(8):643-652.
[65]NAKANO K, BOYLE D L, FIRESTEIN G S. Regulation of DNA methylation in rheumatoid arthritis synoviocytes[J]. J Immunol,2013,190(3):1297-1303.
[66]KAROUZAKIS E,TRENKMANN M, GAY R E, et al. Epigenome analysis reveals TBX5 as a novel transcription factor involved in the activation of rheumatoid arthritis synovial fibroblasts[J].J Immunol,2014,193(10):4945-4951.
[67]STANCZYK J, PEDRIOLI D M, BRENTANO F, et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis[J]. Arthritis Rheum,2008,58(4):1001-1009.
[68]STANCZYK J, OSPELT C, KAROUZAKIS E, et al. Altered expression of miR-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation[J].Arthritis Rheum,2010,63(2):373-381.
[69]DE LA RICA L, URQUIZA J M, GO′MEZ-CABRERO D, et al. Identification of novel markers in rheumatoid arthritis through integrated analysis of DNA methylation and microRNA expression[J]. J Autoimmun,2013,41(3):6-16.
[70]TRENKMANN M, BROCK M, GAY R E, et al. Tumor necrosis factor α-induced microRNA-18a activates rheumatoid arthritis synovial fibroblasts through a feedback Loop in NF-κB signaling[J]. Arthritis Rheum,2013,65(4):916-927.
[71]LI X, TIAN F, WANG F. Rheumatoid arthritis-associated microRNA-155 targets SOCS1 and upregulates TNF-αand IL-1βin PBMCs[J]. Int Mol Sci,2013,14(12):23910-23921.
[72]LIN J, HUO R, XIAO L, et al. A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis[J]. Arthr Rheumatol,2014,66(1):49-59.
[73]PHILIPPE L, ALSALEH G, PICHOT A, et al. MiR-20a regulates ASK1 expression and TLR4-dependent cytokine release in rheumatoid fibroblast-like synoviocytes[J].Ann Rheum Dis, 2013,72(6):1071-1079.
[74]MACIEJEWSKA R H, JNGEL A, GAY R E,et al. Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis[J]. Mol Immunol,2009,47(1):12-18.
[75]BRENTANO F, KYBURZ D, GAY S. Toll-like receptors and rheumatoid arthritis[J].Methods Mol Biol,2009,517:329-343.
[76]SOMMERFELT R M, FEUERHERM A J, SKULAND T, et al. Cytosolic phospholipase A2 modulates TLR2 signaling in synoviocytes[J]. PLoS One,2015,10(4):e0119088.
[77]MCGARRY T, VEALE D J, GAO W, et al. Toll-like receptor 2 (TLR2) induces migration and invasive mechanisms in rheumatoid arthritis[J].Arthritis Res Ther,2015,17(1):153.
[78]吕邵娃,王秋实,赵爽,等.中药调控类风湿性关节炎核因子κB信号通路的研究进展[J].细胞与分子免疫学杂志,2015(11):1580-1583.
[79]HOSOYA T, IWAI H, YAMAGUCHI Y,et al.Cell cycle regulation therapy combined with cytokine blockade enhances antiarthritic effects without increasing immune suppression[J].Ann Rheum Dis, 2016,75(1):253-259.